Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/12/2025

Hyperkalemia Management

Introduction to Hyperkalemia

  • The European Society of Cardiology recommends that hyperkalemia with EKG changes be treated as a life-threatening emergency, requiring immediate intervention with IV calcium gluconate and insulin-glucose therapy, as excess potassium can lead to cardiac arrest 1.

Pathophysiology of Hyperkalemia

  • Decreased renal potassium excretion is the dominant cause of hyperkalemia, occurring in up to 73% of patients with advanced chronic kidney disease, and is often associated with medications such as RAAS inhibitors, potassium-sparing diuretics, and NSAIDs 1, 5.

High-Risk Patient Populations

  • Patients with advanced CKD, heart failure, diabetes mellitus, and advanced age have a dramatically elevated risk of hyperkalemia, with renal failure, drugs, and hyperglycemia contributing to most hyperkalemia episodes in hospitalized patients 5.

Critical Diagnostic Considerations

  • Pseudohyperkalemia, caused by hemolysis during blood draw, prolonged tourniquet application, fist clenching, or thrombocytosis/leukocytosis, can lead to falsely elevated potassium levels and should be ruled out by repeating the measurement with proper technique or obtaining an arterial sample 1, 5.

Management of Hyperkalemia

  • The American Heart Association recommends urgent treatment of hyperkalemia with EKG abnormalities using IV calcium gluconate to stabilize cardiac membranes, followed by insulin-glucose therapy and consideration of hemodialysis for severe cases (>6.5 mEq/L) 6.
  • The European Society of Cardiology suggests stopping or reducing potassium-wasting medications, evaluating renal function, and checking for metabolic acidosis, tissue breakdown, or insulin deficiency to address the underlying cause of hyperkalemia 1, 6.

Treatment of Vitamin Deficiencies

  • If SIBO is present, the American Gastroenterological Association recommends confirming the diagnosis through hydrogen/methane breath testing or small bowel aspiration during endoscopy, and screening for fat-soluble vitamin deficiencies with serum retinol, 25-hydroxyvitamin D, alpha-tocopherol, vitamin K1, and PIVKA-II levels 4.
  • The National Institutes of Health suggests supplementing with water-miscible forms of vitamins A, D, E, K, and B12 to treat deficiencies associated with SIBO 4.